Segments of Business and Geographic Areas - Sales By Segment Of Business (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 29, 2020	Mar. 31, 2019
Sales by segment of business
Sales to customers	$ 20,691	$ 20,021
Percent Change (as a percent)	3.30%
U.S.
Sales by segment of business
Sales to customers	$ 10,699	10,129
Percent Change (as a percent)	5.60%
International
Sales by segment of business
Sales to customers	$ 9,992	9,892
Percent Change (as a percent)	1.00%
Consumer Health
Sales by segment of business
Sales to customers	$ 3,625	3,318
Percent Change (as a percent)	9.20%
Consumer Health | U.S.
Sales by segment of business
Sales to customers	$ 1,740	1,438
Percent Change (as a percent)	21.00%
Consumer Health | International
Sales by segment of business
Sales to customers	$ 1,885	1,880
Percent Change (as a percent)	0.30%
Consumer Health | Baby Care
Sales by segment of business
Sales to customers	$ 361	394
Percent Change (as a percent)	(8.20%)
Consumer Health | Baby Care | U.S.
Sales by segment of business
Sales to customers	$ 92	87
Percent Change (as a percent)	6.70%
Consumer Health | Baby Care | International
Sales by segment of business
Sales to customers	$ 269	307
Percent Change (as a percent)	(12.40%)
Consumer Health | Skin Health/Beauty
Sales by segment of business
Sales to customers	$ 1,117	1,090
Percent Change (as a percent)	2.50%
Consumer Health | Skin Health/Beauty | U.S.
Sales by segment of business
Sales to customers	$ 659	588
Percent Change (as a percent)	12.10%
Consumer Health | Skin Health/Beauty | International
Sales by segment of business
Sales to customers	$ 458	502
Percent Change (as a percent)	(8.80%)
Consumer Health | Oral Care
Sales by segment of business
Sales to customers	$ 395	367
Percent Change (as a percent)	7.60%
Consumer Health | Oral Care | U.S.
Sales by segment of business
Sales to customers	$ 176	151
Percent Change (as a percent)	16.20%
Consumer Health | Oral Care | International
Sales by segment of business
Sales to customers	$ 219	216
Percent Change (as a percent)	1.50%
Consumer Health | OTC
Sales by segment of business
Sales to customers	$ 1,348	1,087
Percent Change (as a percent)	24.10%
Consumer Health | OTC | U.S.
Sales by segment of business
Sales to customers	$ 689	507
Percent Change (as a percent)	35.90%
Consumer Health | OTC | International
Sales by segment of business
Sales to customers	$ 659	580
Percent Change (as a percent)	13.70%
Consumer Health | Women's Health
Sales by segment of business
Sales to customers	$ 232	225
Percent Change (as a percent)	2.90%
Consumer Health | Women's Health | U.S.
Sales by segment of business
Sales to customers	$ 4	3
Percent Change (as a percent)	32.00%
Consumer Health | Women's Health | International
Sales by segment of business
Sales to customers	$ 228	222
Percent Change (as a percent)	2.50%
Consumer Health | Wound Care/Other
Sales by segment of business
Sales to customers	$ 171	155
Percent Change (as a percent)	10.70%
Consumer Health | Wound Care/Other | U.S.
Sales by segment of business
Sales to customers	$ 119	102
Percent Change (as a percent)	17.00%
Consumer Health | Wound Care/Other | International
Sales by segment of business
Sales to customers	$ 52	53
Percent Change (as a percent)	(1.20%)
PHARMACEUTICAL
Sales by segment of business
Sales to customers	$ 11,134	10,244
Percent Change (as a percent)	8.70%
PHARMACEUTICAL | U.S.
Sales by segment of business
Sales to customers	$ 6,061	5,582
Percent Change (as a percent)	8.60%
PHARMACEUTICAL | International
Sales by segment of business
Sales to customers	$ 5,073	4,662
Percent Change (as a percent)	8.80%
PHARMACEUTICAL | Immunology
Sales by segment of business
Sales to customers	$ 3,638	3,251
Percent Change (as a percent)	11.90%
PHARMACEUTICAL | Immunology | U.S.
Sales by segment of business
Sales to customers	$ 2,410	2,163
Percent Change (as a percent)	11.40%
PHARMACEUTICAL | Immunology | International
Sales by segment of business
Sales to customers	$ 1,228	1,088
Percent Change (as a percent)	12.80%
PHARMACEUTICAL | Immunology | REMICADE®
Sales by segment of business
Sales to customers	$ 990	1,102
Percent Change (as a percent)	(10.20%)
PHARMACEUTICAL | Immunology | REMICADE® | U.S.
Sales by segment of business
Sales to customers	$ 625	774
Percent Change (as a percent)	(19.30%)
PHARMACEUTICAL | Immunology | REMICADE® | U.S. Exports
Sales by segment of business
Sales to customers	$ 110	76
Percent Change (as a percent)	44.30%
PHARMACEUTICAL | Immunology | REMICADE® | International
Sales by segment of business
Sales to customers	$ 256	252
Percent Change (as a percent)	1.50%
PHARMACEUTICAL | Immunology | SIMPONI / SIMPONI ARIA®
Sales by segment of business
Sales to customers	$ 529	524
Percent Change (as a percent)	1.10%
PHARMACEUTICAL | Immunology | SIMPONI / SIMPONI ARIA® | U.S.
Sales by segment of business
Sales to customers	$ 272	263
Percent Change (as a percent)	3.40%
PHARMACEUTICAL | Immunology | SIMPONI / SIMPONI ARIA® | International
Sales by segment of business
Sales to customers	$ 258	261
Percent Change (as a percent)	(1.20%)
PHARMACEUTICAL | Immunology | STELARA®
Sales by segment of business
Sales to customers	$ 1,819	1,405
Percent Change (as a percent)	29.50%
PHARMACEUTICAL | Immunology | STELARA® | U.S.
Sales by segment of business
Sales to customers	$ 1,217	882
Percent Change (as a percent)	37.90%
PHARMACEUTICAL | Immunology | STELARA® | International
Sales by segment of business
Sales to customers	$ 603	523
Percent Change (as a percent)	15.20%
PHARMACEUTICAL | Immunology | TREMFYA®
Sales by segment of business
Sales to customers	$ 296	217
Percent Change (as a percent)	36.40%
PHARMACEUTICAL | Immunology | TREMFYA® | U.S.
Sales by segment of business
Sales to customers	$ 187	168
Percent Change (as a percent)	11.50%
PHARMACEUTICAL | Immunology | TREMFYA® | International
Sales by segment of business
Sales to customers	$ 109	49
PHARMACEUTICAL | Immunology | OTHER IMMUNOLOGY
Sales by segment of business
Sales to customers	$ 3	3
Percent Change (as a percent)	(6.90%)
PHARMACEUTICAL | Immunology | OTHER IMMUNOLOGY | U.S.
Sales by segment of business
Sales to customers	$ 0	0
Percent Change (as a percent)	0.00%
PHARMACEUTICAL | Immunology | OTHER IMMUNOLOGY | International
Sales by segment of business
Sales to customers	$ 3	3
Percent Change (as a percent)	(6.90%)
PHARMACEUTICAL | Infectious Diseases
Sales by segment of business
Sales to customers	$ 920	846
Percent Change (as a percent)	8.70%
PHARMACEUTICAL | Infectious Diseases | U.S.
Sales by segment of business
Sales to customers	$ 436	357
Percent Change (as a percent)	22.30%
PHARMACEUTICAL | Infectious Diseases | International
Sales by segment of business
Sales to customers	$ 483	489
Percent Change (as a percent)	(1.20%)
PHARMACEUTICAL | Infectious Diseases | EDURANT® / rilpivirine
Sales by segment of business
Sales to customers	$ 224	211
Percent Change (as a percent)	6.10%
PHARMACEUTICAL | Infectious Diseases | EDURANT® / rilpivirine | U.S.
Sales by segment of business
Sales to customers	$ 12	12
Percent Change (as a percent)	0.60%
PHARMACEUTICAL | Infectious Diseases | EDURANT® / rilpivirine | International
Sales by segment of business
Sales to customers	$ 212	199
Percent Change (as a percent)	6.40%
PHARMACEUTICAL | Infectious Diseases | PREZISTA® / PREZCOBIX® / REZOLSTA® / SYMTUZA®
Sales by segment of business
Sales to customers	$ 579	523
Percent Change (as a percent)	10.80%
PHARMACEUTICAL | Infectious Diseases | PREZISTA® / PREZCOBIX® / REZOLSTA® / SYMTUZA® | U.S.
Sales by segment of business
Sales to customers	$ 396	315
Percent Change (as a percent)	25.50%
PHARMACEUTICAL | Infectious Diseases | PREZISTA® / PREZCOBIX® / REZOLSTA® / SYMTUZA® | International
Sales by segment of business
Sales to customers	$ 184	208
Percent Change (as a percent)	(11.60%)
PHARMACEUTICAL | Infectious Diseases | OTHER INFECTIOUS DISEASES
Sales by segment of business
Sales to customers	$ 116	112
Percent Change (as a percent)	4.00%
PHARMACEUTICAL | Infectious Diseases | OTHER INFECTIOUS DISEASES | U.S.
Sales by segment of business
Sales to customers	$ 29	30
Percent Change (as a percent)	(3.40%)
PHARMACEUTICAL | Infectious Diseases | OTHER INFECTIOUS DISEASES | International
Sales by segment of business
Sales to customers	$ 87	82
Percent Change (as a percent)	6.70%
PHARMACEUTICAL | Neuroscience
Sales by segment of business
Sales to customers	$ 1,658	1,629
Percent Change (as a percent)	1.80%
PHARMACEUTICAL | Neuroscience | U.S.
Sales by segment of business
Sales to customers	$ 748	723
Percent Change (as a percent)	3.30%
PHARMACEUTICAL | Neuroscience | International
Sales by segment of business
Sales to customers	$ 910	905
Percent Change (as a percent)	0.50%
PHARMACEUTICAL | Neuroscience | CONCERTA® / methylphenidate
Sales by segment of business
Sales to customers	$ 171	214
Percent Change (as a percent)	(20.10%)
PHARMACEUTICAL | Neuroscience | CONCERTA® / methylphenidate | U.S.
Sales by segment of business
Sales to customers	$ 52	97
Percent Change (as a percent)	(46.10%)
PHARMACEUTICAL | Neuroscience | CONCERTA® / methylphenidate | International
Sales by segment of business
Sales to customers	$ 118	116
Percent Change (as a percent)	1.50%
PHARMACEUTICAL | Neuroscience | INVEGA SUSTENNA® / XEPLION® / INVEGA TRINZA® / TREVICTA®
Sales by segment of business
Sales to customers	$ 883	790
Percent Change (as a percent)	11.70%
PHARMACEUTICAL | Neuroscience | INVEGA SUSTENNA® / XEPLION® / INVEGA TRINZA® / TREVICTA® | U.S.
Sales by segment of business
Sales to customers	$ 544	483
Percent Change (as a percent)	12.60%
PHARMACEUTICAL | Neuroscience | INVEGA SUSTENNA® / XEPLION® / INVEGA TRINZA® / TREVICTA® | International
Sales by segment of business
Sales to customers	$ 339	307
Percent Change (as a percent)	10.30%
PHARMACEUTICAL | Neuroscience | RISPERDAL CONSTA®
Sales by segment of business
Sales to customers	$ 170	179
Percent Change (as a percent)	(5.10%)
PHARMACEUTICAL | Neuroscience | RISPERDAL CONSTA® | U.S.
Sales by segment of business
Sales to customers	$ 76	77
Percent Change (as a percent)	(0.30%)
PHARMACEUTICAL | Neuroscience | RISPERDAL CONSTA® | International
Sales by segment of business
Sales to customers	$ 94	102
Percent Change (as a percent)	(8.70%)
PHARMACEUTICAL | Neuroscience | OTHER NEUROSCIENCE
Sales by segment of business
Sales to customers	$ 435	446
Percent Change (as a percent)	(2.50%)
PHARMACEUTICAL | Neuroscience | OTHER NEUROSCIENCE | U.S.
Sales by segment of business
Sales to customers	$ 75	66
Percent Change (as a percent)	12.50%
PHARMACEUTICAL | Neuroscience | OTHER NEUROSCIENCE | International
Sales by segment of business
Sales to customers	$ 360	379
Percent Change (as a percent)	(5.10%)
PHARMACEUTICAL | Oncology
Sales by segment of business
Sales to customers	$ 3,013	2,518
Percent Change (as a percent)	19.70%
PHARMACEUTICAL | Oncology | U.S.
Sales by segment of business
Sales to customers	$ 1,175	962
Percent Change (as a percent)	22.10%
PHARMACEUTICAL | Oncology | International
Sales by segment of business
Sales to customers	$ 1,839	1,556
Percent Change (as a percent)	18.20%
PHARMACEUTICAL | Oncology | DARZALEX®
Sales by segment of business
Sales to customers	$ 937	629
Percent Change (as a percent)	49.00%
PHARMACEUTICAL | Oncology | DARZALEX® | U.S.
Sales by segment of business
Sales to customers	$ 463	352
Percent Change (as a percent)	31.80%
PHARMACEUTICAL | Oncology | DARZALEX® | International
Sales by segment of business
Sales to customers	$ 474	277
Percent Change (as a percent)	70.90%
PHARMACEUTICAL | Oncology | ERLEADA [Member]
Sales by segment of business
Sales to customers	$ 143	61
PHARMACEUTICAL | Oncology | ERLEADA [Member] | U.S.
Sales by segment of business
Sales to customers	119	58
PHARMACEUTICAL | Oncology | ERLEADA [Member] | International
Sales by segment of business
Sales to customers	24	3
PHARMACEUTICAL | Oncology | IMBRUVICA®
Sales by segment of business
Sales to customers	$ 1,031	784
Percent Change (as a percent)	31.60%
PHARMACEUTICAL | Oncology | IMBRUVICA® | U.S.
Sales by segment of business
Sales to customers	$ 432	349
Percent Change (as a percent)	23.90%
PHARMACEUTICAL | Oncology | IMBRUVICA® | International
Sales by segment of business
Sales to customers	$ 599	435
Percent Change (as a percent)	37.80%
PHARMACEUTICAL | Oncology | VELCADE®
Sales by segment of business
Sales to customers	$ 108	263
Percent Change (as a percent)	(59.00%)
PHARMACEUTICAL | Oncology | VELCADE® | U.S.
Sales by segment of business
Sales to customers	$ 0	0
Percent Change (as a percent)	0.00%
PHARMACEUTICAL | Oncology | VELCADE® | International
Sales by segment of business
Sales to customers	$ 108	263
Percent Change (as a percent)	(59.00%)
PHARMACEUTICAL | Oncology | ZYTIGA® / abiraterone acetate
Sales by segment of business
Sales to customers	$ 690	679
Percent Change (as a percent)	1.60%
PHARMACEUTICAL | Oncology | ZYTIGA® / abiraterone acetate | U.S.
Sales by segment of business
Sales to customers	$ 139	185
Percent Change (as a percent)	(25.20%)
PHARMACEUTICAL | Oncology | ZYTIGA® / abiraterone acetate | International
Sales by segment of business
Sales to customers	$ 552	494
Percent Change (as a percent)	11.70%
PHARMACEUTICAL | Oncology | OTHER ONCOLOGY
Sales by segment of business
Sales to customers	$ 104	102
Percent Change (as a percent)	1.30%
PHARMACEUTICAL | Oncology | OTHER ONCOLOGY | U.S.
Sales by segment of business
Sales to customers	$ 22	18
Percent Change (as a percent)	20.10%
PHARMACEUTICAL | Oncology | OTHER ONCOLOGY | International
Sales by segment of business
Sales to customers	$ 82	84
Percent Change (as a percent)	(2.70%)
PHARMACEUTICAL | Pulmonary Hypertension
Sales by segment of business
Sales to customers	$ 745	656
Percent Change (as a percent)	13.70%
PHARMACEUTICAL | Pulmonary Hypertension | U.S.
Sales by segment of business
Sales to customers	$ 486	430
Percent Change (as a percent)	13.00%
PHARMACEUTICAL | Pulmonary Hypertension | International
Sales by segment of business
Sales to customers	$ 260	226
Percent Change (as a percent)	14.90%
PHARMACEUTICAL | Pulmonary Hypertension | OPSUMIT®
Sales by segment of business
Sales to customers	$ 389	306
Percent Change (as a percent)	27.40%
PHARMACEUTICAL | Pulmonary Hypertension | OPSUMIT® | U.S.
Sales by segment of business
Sales to customers	$ 229	172
Percent Change (as a percent)	33.00%
PHARMACEUTICAL | Pulmonary Hypertension | OPSUMIT® | International
Sales by segment of business
Sales to customers	$ 160	133
Percent Change (as a percent)	20.20%
PHARMACEUTICAL | Pulmonary Hypertension | UPTRAVI®
Sales by segment of business
Sales to customers	$ 250	198
Percent Change (as a percent)	26.20%
PHARMACEUTICAL | Pulmonary Hypertension | UPTRAVI® | U.S.
Sales by segment of business
Sales to customers	$ 212	176
Percent Change (as a percent)	20.70%
PHARMACEUTICAL | Pulmonary Hypertension | UPTRAVI® | International
Sales by segment of business
Sales to customers	$ 38	22
Percent Change (as a percent)	70.20%
PHARMACEUTICAL | Pulmonary Hypertension | OTHER PULMONARY HYPERTENSION
Sales by segment of business
Sales to customers	$ 106	152
Percent Change (as a percent)	(30.40%)
PHARMACEUTICAL | Pulmonary Hypertension | OTHER PULMONARY HYPERTENSION | U.S.
Sales by segment of business
Sales to customers	$ 44	82
Percent Change (as a percent)	(45.90%)
PHARMACEUTICAL | Pulmonary Hypertension | OTHER PULMONARY HYPERTENSION | International
Sales by segment of business
Sales to customers	$ 62	71
Percent Change (as a percent)	(12.40%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other
Sales by segment of business
Sales to customers	$ 1,160	1,345
Percent Change (as a percent)	(13.80%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | U.S.
Sales by segment of business
Sales to customers	$ 806	947
Percent Change (as a percent)	(14.90%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | International
Sales by segment of business
Sales to customers	$ 354	398
Percent Change (as a percent)	(11.00%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | XARELTO®
Sales by segment of business
Sales to customers	$ 527	542
Percent Change (as a percent)	(2.70%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | XARELTO® | U.S.
Sales by segment of business
Sales to customers	$ 527	542
Percent Change (as a percent)	(2.70%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | XARELTO® | International
Sales by segment of business
Sales to customers	$ 0	0
Percent Change (as a percent)	0.00%
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | INVOKANA® / INVOKAMET®
Sales by segment of business
Sales to customers	$ 175	202
Percent Change (as a percent)	(13.50%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | INVOKANA® / INVOKAMET® | U.S.
Sales by segment of business
Sales to customers	$ 117	154
Percent Change (as a percent)	(23.60%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | INVOKANA® / INVOKAMET® | International
Sales by segment of business
Sales to customers	$ 58	49
Percent Change (as a percent)	18.60%
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | PROCRIT® / EPREX®
Sales by segment of business
Sales to customers	$ 155	226
Percent Change (as a percent)	(31.60%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | PROCRIT® / EPREX® | U.S.
Sales by segment of business
Sales to customers	$ 76	148
Percent Change (as a percent)	(48.50%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | PROCRIT® / EPREX® | International
Sales by segment of business
Sales to customers	$ 79	78
Percent Change (as a percent)	0.40%
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | OTHER PULMONARY HYPERTENSION
Sales by segment of business
Sales to customers	$ 302	374
Percent Change (as a percent)	(19.20%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | OTHER PULMONARY HYPERTENSION | U.S.
Sales by segment of business
Sales to customers	$ 85	104
Percent Change (as a percent)	(18.00%)
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | OTHER PULMONARY HYPERTENSION | International
Sales by segment of business
Sales to customers	$ 217	271
Percent Change (as a percent)	(19.70%)
MEDICAL DEVICES
Sales by segment of business
Sales to customers	$ 5,932	6,459
Percent Change (as a percent)	(8.20%)
MEDICAL DEVICES | U.S.
Sales by segment of business
Sales to customers	$ 2,898	3,109
Percent Change (as a percent)	(6.80%)
MEDICAL DEVICES | International
Sales by segment of business
Sales to customers	$ 3,034	3,350
Percent Change (as a percent)	(9.40%)
MEDICAL DEVICES | Interventional Solutions
Sales by segment of business
Sales to customers	$ 727	732
Percent Change (as a percent)	(0.60%)
MEDICAL DEVICES | Interventional Solutions | U.S.
Sales by segment of business
Sales to customers	$ 365	343
Percent Change (as a percent)	6.60%
MEDICAL DEVICES | Interventional Solutions | International
Sales by segment of business
Sales to customers	$ 362	389
Percent Change (as a percent)	(6.90%)
MEDICAL DEVICES | Orthopaedics
Sales by segment of business
Sales to customers	$ 2,038	2,204
Percent Change (as a percent)	(7.50%)
MEDICAL DEVICES | Orthopaedics | U.S.
Sales by segment of business
Sales to customers	$ 1,250	1,318
Percent Change (as a percent)	(5.20%)
MEDICAL DEVICES | Orthopaedics | International
Sales by segment of business
Sales to customers	$ 788	885
Percent Change (as a percent)	(11.00%)
MEDICAL DEVICES | Orthopaedics | HIPS
Sales by segment of business
Sales to customers	$ 337	361
Percent Change (as a percent)	(6.70%)
MEDICAL DEVICES | Orthopaedics | HIPS | U.S.
Sales by segment of business
Sales to customers	$ 206	213
Percent Change (as a percent)	(3.60%)
MEDICAL DEVICES | Orthopaedics | HIPS | International
Sales by segment of business
Sales to customers	$ 132	148
Percent Change (as a percent)	(11.20%)
MEDICAL DEVICES | Orthopaedics | KNEES
Sales by segment of business
Sales to customers	$ 343	369
Percent Change (as a percent)	(7.00%)
MEDICAL DEVICES | Orthopaedics | KNEES | U.S.
Sales by segment of business
Sales to customers	$ 214	223
Percent Change (as a percent)	(4.20%)
MEDICAL DEVICES | Orthopaedics | KNEES | International
Sales by segment of business
Sales to customers	$ 130	146
Percent Change (as a percent)	(11.40%)
MEDICAL DEVICES | Orthopaedics | TRAUMA
Sales by segment of business
Sales to customers	$ 654	685
Percent Change (as a percent)	(4.50%)
MEDICAL DEVICES | Orthopaedics | TRAUMA | U.S.
Sales by segment of business
Sales to customers	$ 407	417
Percent Change (as a percent)	(2.30%)
MEDICAL DEVICES | Orthopaedics | TRAUMA | International
Sales by segment of business
Sales to customers	$ 247	268
Percent Change (as a percent)	(8.00%)
MEDICAL DEVICES | Orthopaedics | SPINE, SPORTS & OTHER
Sales by segment of business
Sales to customers	$ 703	788
Percent Change (as a percent)	(10.70%)
MEDICAL DEVICES | Orthopaedics | SPINE, SPORTS & OTHER | U.S.
Sales by segment of business
Sales to customers	$ 423	465
Percent Change (as a percent)	(8.90%)
MEDICAL DEVICES | Orthopaedics | SPINE, SPORTS & OTHER | International
Sales by segment of business
Sales to customers	$ 280	323
Percent Change (as a percent)	(13.30%)
MEDICAL DEVICES | Surgery
Sales by segment of business
Sales to customers	$ 2,100	2,395
Percent Change (as a percent)	(12.30%)
MEDICAL DEVICES | Surgery | U.S.
Sales by segment of business
Sales to customers	$ 844	1,001
Percent Change (as a percent)	(15.70%)
MEDICAL DEVICES | Surgery | International
Sales by segment of business
Sales to customers	$ 1,257	1,394
Percent Change (as a percent)	(9.80%)
MEDICAL DEVICES | Surgery | ADVANCED
Sales by segment of business
Sales to customers	$ 948	980
Percent Change (as a percent)	(3.30%)
MEDICAL DEVICES | Surgery | ADVANCED | U.S.
Sales by segment of business
Sales to customers	$ 381	404
Percent Change (as a percent)	(5.70%)
MEDICAL DEVICES | Surgery | ADVANCED | International
Sales by segment of business
Sales to customers	$ 567	576
Percent Change (as a percent)	(1.60%)
MEDICAL DEVICES | Surgery | GENERAL
Sales by segment of business
Sales to customers	$ 1,153	1,414
Percent Change (as a percent)	(18.50%)
MEDICAL DEVICES | Surgery | GENERAL | U.S.
Sales by segment of business
Sales to customers	$ 463	597
Percent Change (as a percent)	(22.50%)
MEDICAL DEVICES | Surgery | GENERAL | International
Sales by segment of business
Sales to customers	$ 690	818
Percent Change (as a percent)	(15.70%)
MEDICAL DEVICES | Vision
Sales by segment of business
Sales to customers	$ 1,067	1,129
Percent Change (as a percent)	(5.50%)
MEDICAL DEVICES | Vision | U.S.
Sales by segment of business
Sales to customers	$ 439	446
Percent Change (as a percent)	(1.60%)
MEDICAL DEVICES | Vision | International
Sales by segment of business
Sales to customers	$ 628	682
Percent Change (as a percent)	(8.00%)
MEDICAL DEVICES | Vision | CONTACT LENSES / OTHER
Sales by segment of business
Sales to customers	$ 814	824
Percent Change (as a percent)	(1.30%)
MEDICAL DEVICES | Vision | CONTACT LENSES / OTHER | U.S.
Sales by segment of business
Sales to customers	$ 346	321
Percent Change (as a percent)	7.70%
MEDICAL DEVICES | Vision | CONTACT LENSES / OTHER | International
Sales by segment of business
Sales to customers	$ 467	502
Percent Change (as a percent)	(7.00%)
MEDICAL DEVICES | Vision | SURGICAL
Sales by segment of business
Sales to customers	$ 253	305
Percent Change (as a percent)	(16.90%)
MEDICAL DEVICES | Vision | SURGICAL | U.S.
Sales by segment of business
Sales to customers	$ 93	125
Percent Change (as a percent)	(25.50%)
MEDICAL DEVICES | Vision | SURGICAL | International
Sales by segment of business
Sales to customers	$ 160	$ 180
Percent Change (as a percent)	(11.00%)